| Prediction type | Cancer type | No of patients | Type of data | Accuracy | Validation method | Important features | Reference |
| Susceptibility | Breast cancer | 62,219 | Mammographic, demographic | 96.5% | 10-fold cross-validation | Age, mammography findings | [58] |
| Survival | Lung cancer | 440 | Clinical, gene expression | 83.5% | Cross-validation | Sex, age, T_stage, N_stage, LCK and ERBB2 genes | [59] |